$1.22
2.40% yesterday
Nasdaq, Jun 13, 10:00 pm CET
ISIN
US0043971052
Symbol
ARAY

Accuray Incorporated Stock price

$1.22
-0.44 26.51% 1M
-0.70 36.46% 6M
-0.76 38.38% YTD
-0.54 30.68% 1Y
-1.06 46.49% 5Y
-5.76 82.52% 10Y
-27.25 95.71% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
-0.03 2.40%
ISIN
US0043971052
Symbol
ARAY
Sector

Key metrics

Market capitalization $128.77m
Enterprise Value $224.73m
P/E (TTM) P/E ratio 125.00
EV/FCF (TTM) EV/FCF 11.81
EV/Sales (TTM) EV/Sales 0.48
P/S ratio (TTM) P/S ratio 0.28
P/B ratio (TTM) P/B ratio 2.59
Revenue growth (TTM) Revenue growth 8.05%
Revenue (TTM) Revenue $465.25m
EBIT (operating result TTM) EBIT $10.42m
Free Cash Flow (TTM) Free Cash Flow $19.03m
Cash position $77.82m
EPS (TTM) EPS $0.01
P/E forward negative
P/S forward 0.28
EV/Sales forward 0.49
Short interest 4.25%
Show more

Is Accuray Incorporated a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Accuray Incorporated Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Accuray Incorporated forecast:

4x Buy
100%

Analyst Opinions

4 Analysts have issued a Accuray Incorporated forecast:

Buy
100%

Financial data from Accuray Incorporated

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
465 465
8% 8%
100%
- Direct Costs 319 319
11% 11%
69%
146 146
3% 3%
31%
- Selling and Administrative Expenses 90 90
4% 4%
19%
- Research and Development Expense 46 46
13% 13%
10%
16 16
1,339% 1,339%
4%
- Depreciation and Amortization 6.06 6.06
10% 10%
1%
EBIT (Operating Income) EBIT 10 10
253% 253%
2%
Net Profit 0.67 0.67
103% 103%
0%

In millions USD.

Don't miss a Thing! We will send you all news about Accuray Incorporated directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Accuray Incorporated Stock News

Neutral
PRNewsWire
8 days ago
MADISON, Wis. , June 6, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that, after an extensive review over the last several months, including the evaluation of numerous potential financing partners, it has entered into privately negotiated agreements with the holders of its existing 3.75% senior convertible notes due 2026 (the "Notes") to exchange an aggregate of $82....
Neutral
PRNewsWire
15 days ago
MADISON, Wis. , May 29, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2025.
Neutral
PRNewsWire
about one month ago
More than 40 Clinical Studies Using Accuray Technology Presented at ESTRO 2025; Company Highlights Innovation and Educational Symposia MADISON, Wis. , May 7, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the European Society for Radiotherapy and Oncology (ESTRO) meeting reinforces the benefits of the company's CyberKnife ® System in the trea...
More Accuray Incorporated News

Company Profile

Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.

Head office United States
CEO Suzanne Winter
Employees 987
Founded 1990
Website www.accuray.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today